The research interests of Svetomir N. Markovic, M.D., Ph.D., center on translational immunotherapeutics of cancer focused on malignant melanoma and non-Hodgkin's lymphoma. This work includes development and clinical testing of cancer vaccines, immune-boosting agents, novel agents that reconstitute immunity in patients with cancer, and combination therapy directed at enhancing anti-tumor immune responses.
- Discovery of biological processes that are utilized by cancers to overcome anti-tumor immunity in humans
- Discovery and translation into clinical studies of novel agents that favor anti-tumor immunity in patients with melanoma and non-Hodgkin's lymphoma
- Understanding ways to integrate different modes of cancer therapy into comprehensive treatment strategies yielding significant improvements in patient outcomes
Significance to patient care
All of Dr. Markovic's research activities are centered on the principle of developing more effective and less toxic therapies for advanced cancers such as melanoma and non-Hodgkin's lymphoma.